Alnylam Pharmaceuticals (ALNY) Stock Insights

ALNY price $229.16 +2.37 +1.05%

Ticker
ALNY
Price
$229.16
Change
+2.37 +1.05%
Market cap ?
$30.66B
P/E ?
37.32
Forward P/E ?
35.31
Dividend yield ?
0.00%
Beta ?
0.27
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
51
Quality
80
Growth
80

Stocklytics score rationale: value 51, quality 80, growth 80.

Financials

2016201720182019202020212022202320242025
4715900089912000749080002197500004928530008442870001037418000182829200022482430003713937000

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company primarily dedicated to the discovery, development, and commercialization of innovative therapeutic solutions leveraging ribonucleic acid interference (RNAi) technology. Its robust pipeline of RNAi-based treatments addresses a range of critical therapeutic areas, including inherited genetic disorders, cardio-metabolic conditions, hepatic infectious…

Fair value

ALNY fair value $371.50. Price $229.16. Price is 38% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 95% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare ALNY

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—1.66—1.43B
2026-07-301.211.631.29B1.32B
2026-04-301.510.871.17B1.12B
2026-02-120.821.161.10B1.15B
2025-10-301.840.561.25B959.40M
2025-07-31-0.51-0.54773.69M662.87M
2025-05-01-0.44-0.89594.19M585.14M
2025-02-13-0.65-0.62593.17M582.61M
2024-10-31-0.87-0.92500.92M532.91M
2024-08-01-0.13-1.07659.83M447.22M
2024-05-02-0.52-1.12494.33M428.01M
2024-02-15-1.10-1.20439.72M436.92M
2023-11-021.15-1.34750.53M396.76M
2023-08-03-2.21-1.37318.75M332.28M
2023-05-04-1.40-1.77319.29M312.27M
2023-02-23-1.68-1.90335.04M313.13M
2022-10-27-3.32-1.77264.31M291.66M
2022-07-28-2.29-1.63224.82M255.56M
2022-04-28-2.00-1.84213.26M240.95M
2022-02-10-2.16-1.54258.54M233.61M
2021-10-28-1.72-1.57187.63M219.69M
2021-08-03-1.61-1.61220.55M220.55M
2021-04-29-1.71-1.73177.57M169.04M
2021-02-11-2.09-1.78163.56M146.70M
2020-11-05-2.18-1.64125.85M95.83M
2020-08-06-1.56-1.71103.96M115.96M
2020-05-06-1.62-1.8899.48M116.06M
2020-02-06-2.47-2.2171.68M64.43M
2019-10-31-1.92-2.0470.06M74.44M
2019-08-06-2.02-1.8544.71M41.17M
2019-05-01-1.73-2.0733.29M39.84M
2019-02-07-2.09-2.2121.03M22.24M
2018-11-07-2.43-1.732.07M1.70M
2018-08-02-1.61-1.7529.91M32.11M
2018-05-03-1.41-1.4721.90M22.83M
2018-02-08-1.48-1.3937.92M35.61M
2017-11-07-1.34-1.2617.10M16.08M
2017-08-09-1.34-1.2215.93M14.50M
2017-05-05-1.25-1.2618.96M19.11M
2017-02-08-1.32-1.3317.45M17.58M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-02SUPRAN BRYANSell1.76K$226.88398.86K
2026-09-19Greenstreet YvonneBuy107——
2026-06-01PYOTT DAVID E IBuy3.83K——
2026-06-01PYOTT DAVID E ISell921$297.71274.19K
2026-06-01PYOTT DAVID E ISell1.18K$298.91351.22K
2026-06-01PYOTT DAVID E ISell1.22K$299.87366.44K
2026-06-01PYOTT DAVID E ISell495$300.72148.86K
2026-06-01PYOTT DAVID E ISell17$302.655.15K
2026-06-01PYOTT DAVID E ISell3.83K$70.20268.87K
2026-06-01Cravatt BenjaminBuy4.39K$295.631.30M
2026-06-01Cravatt BenjaminOther0——
2026-05-20Sigal Charles ElliottBuy671——
2026-05-20Sigal Charles ElliottBuy1.44K$298.48430.11K
2026-05-20SCHULMAN AMY WBuy838——
2026-05-20SCHULMAN AMY WBuy1.80K$298.48537.86K
2026-05-20Reitan Colleen FBuy671——
2026-05-20Reitan Colleen FBuy1.44K$298.48430.11K
2026-05-20PYOTT DAVID E IBuy671——
2026-05-20PYOTT DAVID E IBuy1.44K$298.48430.11K
2026-05-20KELLOGG PETER NBuy671——
2026-05-20KELLOGG PETER NBuy1.44K$298.48430.11K
2026-05-20HAMBURG MARGARET ABuy671——
2026-05-20HAMBURG MARGARET ABuy1.44K$298.48430.11K
2026-05-20BRANDICOURT OLIVIERBuy671——
2026-05-20BRANDICOURT OLIVIERBuy1.44K$298.48430.11K
2026-05-20Ausiello Dennis ABuy671——
2026-05-20Ausiello Dennis ABuy1.44K$298.48430.11K
2026-05-20Arbuckle Stuart ABuy1.44K$298.48430.11K
2026-05-20Arbuckle Stuart ABuy671——
2026-05-13SCHULMAN AMY WBuy11.25K$70.20789.75K
2026-05-13SCHULMAN AMY WSell11.25K$70.20789.75K
2026-04-06McLaughlin MelissaSell56$320.1417.93K
2026-04-06McLaughlin MelissaSell909$329.76299.75K
2026-04-06McLaughlin MelissaSell829$330.46273.95K
2026-04-06McLaughlin MelissaSell293$331.8997.24K
2026-04-06McLaughlin MelissaSell199$333.9466.45K
2026-04-02McLaughlin MelissaSell265$316.6183.90K
2026-04-02McLaughlin MelissaSell359$317.44113.96K
2026-04-02McLaughlin MelissaSell209$318.4766.56K
2026-04-02McLaughlin MelissaSell86$319.6927.49K
2026-04-02McLaughlin MelissaSell147$320.6247.13K
2026-04-02McLaughlin MelissaSell224$321.6472.05K
2026-04-02McLaughlin MelissaSell245$322.8679.10K
2026-04-02McLaughlin MelissaSell81$323.6426.21K
2026-04-02McLaughlin MelissaSell8$325.492.60K
2026-03-25McLaughlin MelissaOther0——
2026-03-25McLaughlin MelissaOther3.57K$325.071.16M
2026-03-05Garg PushkalSell654$322.33210.80K
2026-03-05Garg PushkalSell740$323.55239.43K
2026-03-05Garg PushkalSell510$324.59165.54K
2026-03-05Garg PushkalSell500$326.08163.04K
2026-03-05Fitzgerald Kevin JosephSell124$321.8139.90K
2026-03-05Fitzgerald Kevin JosephSell233$323.2575.32K
2026-03-05Fitzgerald Kevin JosephSell148$324.6048.04K
2026-03-05Fitzgerald Kevin JosephSell153$326.2449.91K
2026-03-04Garg PushkalSell106$319.0333.82K
2026-03-04Garg PushkalSell102$320.0132.64K
2026-03-04Garg PushkalSell215$320.8168.97K
2026-03-04Garg PushkalSell289$321.8293.01K
2026-03-04Garg PushkalSell350$323.01113.05K
2026-03-04Garg PushkalSell767$323.84248.39K
2026-03-04Garg PushkalSell272$324.8888.37K
2026-03-04Garg PushkalSell208$325.6767.74K
2026-03-04Greenstreet YvonneSell135$319.0343.07K
2026-03-04Greenstreet YvonneSell129$320.0141.28K
2026-03-04Greenstreet YvonneSell274$320.8187.90K
2026-03-04Greenstreet YvonneSell368$321.82118.43K
2026-03-04Greenstreet YvonneSell444$323.01143.42K
2026-03-04Greenstreet YvonneSell973$323.84315.10K
2026-03-04Greenstreet YvonneSell345$324.88112.08K
2026-03-04Greenstreet YvonneSell265$325.6786.30K
2026-03-04Poulton Jeffrey V.Sell114$319.0336.37K
2026-03-04Poulton Jeffrey V.Sell109$320.0134.88K
2026-03-04Poulton Jeffrey V.Sell230$320.8173.79K
2026-03-04Poulton Jeffrey V.Sell309$321.8299.44K
2026-03-04Poulton Jeffrey V.Sell374$323.01120.81K
2026-03-04Poulton Jeffrey V.Sell818$323.84264.90K
2026-03-04Poulton Jeffrey V.Sell291$324.8894.54K
2026-03-04Poulton Jeffrey V.Sell223$325.6772.62K
2026-03-04Tanguler TolgaSell106$319.0333.82K
2026-03-04Tanguler TolgaSell102$320.0132.64K
2026-03-04Tanguler TolgaSell215$320.8168.97K
2026-03-04Tanguler TolgaSell289$321.8293.01K
2026-03-04Tanguler TolgaSell350$323.01113.05K
2026-03-04Tanguler TolgaSell767$323.84248.39K
2026-03-04Tanguler TolgaSell272$324.8888.37K
2026-03-04Tanguler TolgaSell208$325.6767.74K
2026-03-04Fitzgerald Kevin JosephSell29$319.039.25K
2026-03-04Fitzgerald Kevin JosephSell28$320.018.96K
2026-03-04Fitzgerald Kevin JosephSell59$320.8118.93K
2026-03-04Fitzgerald Kevin JosephSell79$321.8225.42K
2026-03-04Fitzgerald Kevin JosephSell96$323.0131.01K
2026-03-04Fitzgerald Kevin JosephSell210$323.8468.01K
2026-03-04Fitzgerald Kevin JosephSell75$324.8824.37K
2026-03-04Fitzgerald Kevin JosephSell57$325.6718.56K
2026-03-03Garg PushkalSell355$316.74112.44K
2026-03-03Garg PushkalSell317$319.06101.14K
2026-03-03Garg PushkalSell640$320.48205.11K
2026-03-03Garg PushkalSell463$321.50148.85K
2026-03-03Fitzgerald Kevin JosephSell289$316.5591.48K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 830, holders +2 vs prior quarter. Ownership 100.97%.

HolderSharesChangeChange %Value
FMR LLC15.02M444.80K+3.05%4.52B
CAPITAL WORLD INVESTORS11.14M342.50K+3.17%3.35B
BLACKROCK, INC.10.91M462.77K+4.43%3.28B
CAPITAL RESEARCH GLOBAL INVESTORS9.75M279.52K+2.95%2.94B
VANGUARD PORTFOLIO MANAGEMENT LLC6.54M47.11K+0.73%1.97B
VANGUARD CAPITAL MANAGEMENT LLC6.03M82.77K+1.39%1.82B
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.5.64M448.85K+8.64%1.70B
INVESCO LTD.3.75M970.92K+34.88%1.13B
STATE STREET CORP3.56M232.99K+7.01%1.07B
GEODE CAPITAL MANAGEMENT, LLC2.64M-24.55K-0.92%791.35M
JPMORGAN CHASE & CO2.68M-3.65M-57.69%785.32M
BAILLIE GIFFORD & CO2.44M-53.98K-2.16%734.48M
NORGES BANK2.27M2.27MNew683.88M
WELLINGTON MANAGEMENT GROUP LLP2.11M174.48K+9.01%635.30M
ORBIS ALLAN GRAY LTD1.99M652.58K+48.89%598.27M
DODGE & COX1.96M26.14K+1.35%588.63M
TWO SIGMA INVESTMENTS, LP1.88M-116.64K-5.85%564.71M
AMERICAN CENTURY COMPANIES INC1.85M51.59K+2.86%558.10M
CLEARBRIDGE INVESTMENTS, LLC1.26M-96.55K-7.12%379.14M
PRICE T ROWE ASSOCIATES INC /MD/1.15M-283.55K-19.79%345.94M
D. E. SHAW & CO., INC.1.10M695.31K+170.09%332.37M
MORGAN STANLEY1.03M29.47K+2.94%310.71M
BANK OF AMERICA CORP /DE/994.48K27.56K+2.85%299.37M
LEGAL & GENERAL GROUP PLC924.56K-10.32K-1.10%278.32M
MANUFACTURERS LIFE INSURANCE COMPANY, THE893.79K231.43K+34.94%269.06M

Insights

Revenue by product
PeriodValue
FY2018Product: 12535000.0
FY2019Product: 166537000.0
FY2020Product: 361520000.0
FY2021Product: 662138000.0, Royalty: 1196000.0
FY2022Product: 894329000.0, Royalty: 8177000.0
FY2023GIVLAARI: 219251000.0, Product: 1241474000.0
FY2024GIVLAARI: 255871000.0, Product: 1646228000.0
FY2025AMVUTTRA: 2313836000.0, GIVLAARI: 308487000.0, Net revenues from collaborations: 553366000.0, ONPATTRO: 172789000.0, OXLUMO: 191437000.0, Royalty revenue: 174022000.0
Revenue by region
PeriodValue
FY2019Non-US Or Europe: 50085000.0, UNITED STATES: 116452000.0
FY2020Europe: 333000.0, Non-US Or Europe: 46752000.0, UNITED STATES: 151574000.0
FY2021Europe: 38949000.0, Non-US Or Europe: 1761000.0, UNITED STATES: 18876000.0
FY2022Europe: 37915000.0, Non-US Or Europe: 4169000.0, UNITED STATES: 27698000.0
FY2023Europe: 210916000.0, Non-US Or Europe: 75771000.0, UNITED STATES: 411169000.0
FY2024Europe: 235441000.0, Non-US Or Europe: 104396000.0, UNITED STATES: 630613000.0
FY2025Europe: 405899000.0, Non-US Or Europe: 176715000.0, UNITED STATES: 1731222000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Alnylam Pharmaceuticals (ALNY) Stock Insights

ALNY$229.16+2.37 +1.05%

$30.66B

Market Cap

37.32

P/E

35.31

Forward P/E

70

Score

Price History